Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- HPJ +19.5%, SRPT +18%, DWCH +6.3%, PLXS +6.1%, KMI +4%, HAWK+3.9%, URI +3.6%, TMUS +2.9%, VMI +2.5%, AEHR +2.4%, ABT +1.2%,DOV +1%, EWBC +0.9%, KEY +0.7%, UN +0.7%, FPI +0.6%
M&A news:
- AVA +18.1% (Avista to be acquired by Hydro One for $53/share), CAMT +5.2% (to sell its PCB business for $35 million)
Other news:
- BVXV +10.6% (reports results from the Phase 2b clinical trial of M-001)
- ALIM +6.6% (announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has given final approval to reduce the size of its ILUVIEN Registry Safety Study)
- AEZS +4.7% (continued strength)
- MGM +2.8% (to join S&P 500)
- ERIC +1.8% (slightly rebounding following recent weakness post earnings)
- RMD +1% (to join S&P 500)
- STM +1% (says recent media speculation that it may resume taking MCU orders after year-end is false)
- TEVA +0.9% (receives NICE recommendation for CINQAERO)
Analyst comments:
- NKE +2.3% (upgraded Overweight from Equal-Weight at Morgan Stanley; tgt $68)
- BGS +2.1% (upgraded to Buy from Neutral at Citigroup)
- RCL +0.6% (upgraded to Overweight from Neutral at JP Morgan)